8-KThe WireRoutine
Shareholder Vote
Filed Jun 10, 2026 · 19d ago · Accession 0001193125-26-265934
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Jun 10, 2026
- Report date
- Jun 9, 2026
- Document
- ntla-20260609.htm
- Size
- 208 KB